The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke

Neurotherapeutics

Volumn 13, Issue 4, 2016, Pages 762-774

  Winek, Katarzyna ^a   Dirnagl, Ulrich ^a,b,c   Meisel, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

brain gut microbiota axis; central nervous system; Gut microbiota; stroke; therapeutic target

Indexed keywords

CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; EXPERIMENTAL STUDY; HUMAN; INTESTINE FLORA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; GASTROINTESTINAL MICROBIOME; HUMANS; MICROBIOTA;

EID: 84990858990     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-016-0475-x     Document Type: Review

References (137)

1. Rettger, L.F., A Treatise on the Transformation of the Intestinal Flora. London: Forgotten Books. (Original work published 1921). (2013).
2. Shulman, S.T., Friedmann, H.C., and Sims, R.H., Theodor Escherich: the first pediatric infectious diseases physician? Clin Infect Dis, 2007. 45(8): p. 1025-9.
3. Grice, E.A. and Segre, J.A., The human microbiome: our second genome. Annu Rev Genomics Hum Genet, 2012. 13: p. 151-70.
4. Xu, J. and Gordon, J.I., Honor thy symbionts. Proc Natl Acad Sci U S A, 2003. 100(18): p. 10452-9.
5. O'Hara, A.M. and Shanahan, F., The gut flora as a forgotten organ. EMBO Rep, 2006. 7(7): p. 688-93.
6. Borre, Y.E., O'Keeffe, G.W., Clarke, G., Stanton, C., Dinan, T.G., and Cryan, J.F., Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med, 2014. 20(9): p. 509-18.
7. Butto, L.F. and Haller, D., Dysbiosis in intestinal inflammation: Cause or consequence. Int J Med Microbiol, 2016.
8. Karlsson, F.H., Tremaroli, V., Nookaew, I., et al., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 2013. 498(7452): p. 99-103.
9. Bultman, S.J., Emerging roles of the microbiome in cancer. Carcinogenesis, 2014. 35(2): p. 249-55.
10. Mayer, E.A., Knight, R., Mazmanian, S.K., Cryan, J.F., and Tillisch, K., Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci, 2014. 34(46): p. 15490-6.
11. Scheperjans, F., Aho, V., Pereira, P.A., et al., Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord, 2015. 30(3): p. 350-8.
12. Gungor, B., Adiguzel, E., Gursel, I., Yilmaz, B., and Gursel, M., Intestinal Microbiota in Patients with Spinal Cord Injury. PLoS One, 2016. 11(1): p. e0145878.
13. De Angelis, M., Francavilla, R., Piccolo, M., De Giacomo, A., and Gobbetti, M., Autism spectrum disorders and intestinal microbiota. Gut Microbes, 2015. 6(3): p. 207-13.
14. Yin, J., Liao, S.X., He, Y., et al., Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. J Am Heart Assoc, 2015. 4(11).
15. Houlden, A., Goldrick, M., Brough, D., et al., Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun, 2016.
16. Singh, V., Roth, S., Llovera, G., et al., Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. J Neurosci, 2016. 36(28): p. 7428-40.
17. O'Toole, P.W. and Claesson, M.J., Gut microbiota: Changes throughout the lifespan from infancy to elderly. International Dairy Journal, 2010. 20(4): p. 281-291.
18. Claesson, M.J., Cusack, S., O'Sullivan, O., et al., Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A, 2011. 108 Suppl 1: p. 4586-91.
19. Reardon, S., Microbiome therapy gains market traction. Nature, 2014. 509(7500): p. 269-70.
20. Garber, K., Drugging the gut microbiome. Nat Biotechnol, 2015. 33(3): p. 228-31.
21. Luczynski, P., McVey Neufeld, K.A., Oriach, C.S., Clarke, G., Dinan, T.G., and Cryan, J.F., Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol, 2016.
22. Collins, J., Borojevic, R., Verdu, E.F., Huizinga, J.D., and Ratcliffe, E.M., Intestinal microbiota influence the early postnatal development of the enteric nervous system. Neurogastroenterol Motil, 2014. 26(1): p. 98-107.
23. Braniste, V., Al-Asmakh, M., Kowal, C., et al., The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med, 2014. 6(263): p. 263ra158.
24. Erny, D., Hrabe de Angelis, A.L., Jaitin, D., et al., Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci, 2015. 18(7): p. 965-77.
25. Hoban, A.E., Stilling, R.M., Ryan, F.J., et al., Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry, 2016. 6: p. e774.
26. Heijtz, R.D., Wang, S., Anuar, F., et al., Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences of the United States of America, 2011. 108(7): p. 3047-52.
27. Sudo, N., Chida, Y., Aiba, Y., et al., Postnatal microbial colonization programs the hypothalamic-pituitaryadrenal system for stress response in mice. J Physiol, 2004. 558(Pt 1): p. 263-75.
28. Gareau, M.G., Wine, E., Rodrigues, D.M., et al., Bacterial infection causes stress-induced memory dysfunction in mice. Gut, 2010.
29. Bercik, P., Denou, E., Collins, J., et al., The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice. Gastroenterology, 2011.
30. Bruce-Keller, A.J., Salbaum, J.M., Luo, M., et al., Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry, 2015. 77(7): p. 607-15.
31. Neufeld, K.M., Kang, N., Bienenstock, J., and Foster, J.A., Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil, 2011. 23(3): p. 255-64, e119.
32. Binder, D.K. and Scharfman, H.E., Brain-derived neurotrophic factor. Growth Factors, 2004. 22(3): p. 123-31.
33. Clarke, G., Grenham, S., Scully, P., et al., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry, 2012.
34. Yano, J.M., Yu, K., Donaldson, G.P., et al., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 2015. 161(2): p. 264-76.
35. Wikoff, W.R., Anfora, A.T., Liu, J., et al., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A, 2009. 106(10): p. 3698-703.
36. Collins, S.M., Surette, M., and Bercik, P., The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol, 2012. 10(11): p. 735-42.
37. Cryan, J.F. and Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci, 2012. 13(10): p. 701-12.
38. Rhee, S.H., Pothoulakis, C., and Mayer, E.A., Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol, 2009. 6(5): p. 306-14.
39. Tanida, M., Yamano, T., Maeda, K., Okumura, N., Fukushima, Y., and Nagai, K., Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethaneanesthetized rats. Neurosci Lett, 2005. 389(2): p. 109-14.
40. Bravo, J.A., Forsythe, P., Chew, M.V., et al., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A, 2011. 108(38): p. 16050-5.
41. Bercik, P., Park, A.J., Sinclair, D., et al., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil, 2011. 23(12): p. 1132-9.
42. Ochoa-Reparaz, J., Mielcarz, D.W., Begum-Haque, S., and Kasper, L.H., Gut, bugs, and brain: Role of commensal bacteria in the control of central nervous system disease. Ann Neurol, 2011. 69(2): p. 240-7.
43. Wang, Y. and Kasper, L.H., The role of microbiome in central nervous system disorders. Brain Behav Immun, 2014. 38: p. 1-12.
44. Mayer, E.A., Tillisch, K., and Gupta, A., Gut/brain axis and the microbiota. J Clin Invest, 2015. 125(3): p. 926-38.
45. Berer, K., Mues, M., Koutrolos, M., et al., Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature, 2011. 479(7374): p. 538-41.
46. Lee, Y.K., Menezes, J.S., Umesaki, Y., and Mazmanian, S.K., Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A, 2011. 108 Suppl 1: p. 4615-22.
47. Bettelli, E., Pagany, M., Weiner, H.L., Linington, C., Sobel, R.A., and Kuchroo, V.K., Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med, 2003. 197(9): p. 1073-81.
48. Miller, P.G., Bonn, M.B., Franklin, C.L., Ericsson, A.C., and McKarns, S.C., TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease. J Immunol, 2015. 195(10): p. 4668-84.
49. Nouri, M., Bredberg, A., Westrom, B., and Lavasani, S., Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of autoreactive T cells. PLoS One, 2014. 9(9): p. e106335.
50. Rothhammer, V., Mascanfroni, I.D., Bunse, L., et al., Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med, 2016.
51. Ochoa-Reparaz, J., Mielcarz, D.W., Wang, Y., et al., A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunology, 2010. 3(5): p. 487-495.
52. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and Kasper, D.L., An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 2005. 122(1): p. 107-18.
53. Hsiao, E.Y., McBride, S.W., Hsien, S., et al., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell, 2013. 155(7): p. 1451-63.
54. Tennoune, N., Chan, P., Breton, J., et al., Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide alpha-MSH, at the origin of eating disorders. Transl Psychiatry, 2014. 4: p. e458.
55. Park, A.J., Collins, J., Blennerhassett, P.A., et al., Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil, 2013. 25(9): p. 733-e575.
56. O'Mahony, S.M., Marchesi, J.R., Scully, P., et al., Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry, 2009. 65(3): p. 263-7.
57. De Palma, G., Blennerhassett, P., Lu, J., et al., Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun, 2015. 6: p. 7735.
58. Harach, T.M., N.; Dutilleul, N.; Cheatham, V., et al., Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota. arXiv:1509.02273v2 [q-bio.MN].
59. Minter, M.R., Zhang, C., Leone, V., et al., Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci Rep, 2016. 6: p. 30028.
60. Jandzinski, M., Manipulation of the microbiome and its impact on functional recovery following ischemic stroke. Honors Scholar Theses. Paper 414, 2015: p. http://digitalcommons.uconn.edu/srhonors_theses/414.
61. Tascilar, N., Irkorucu, O., Tascilar, O., et al., Bacterial translocation in experimental stroke: what happens to the gut barrier? Bratisl Lek Listy, 2010. 111(4): p. 194-9.
62. Caso, J.R., Hurtado, O., Pereira, M.P., et al., Colonic bacterial translocation as a possible factor in stressworsening experimental stroke outcome. Am J Physiol Regul Integr Comp Physiol, 2009. 296(4): p. R979-85.
63. Whittaker, R.H., Evolution and Measurement of Species Diversity. Taxon, 1972. 21(2/3): p. 213-251.
64. Benakis, C., Brea, D., Caballero, S., et al., Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med, 2016. 22(5): p. 516-23.
65. Garidou, L., Pomie, C., Klopp, P., et al., The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORgammat and Controls Metabolic Disease. Cell Metab, 2015. 22(1): p. 100-12.
66. Sacco, R.L., Benjamin, E.J., Broderick, J.P., et al., American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke, 1997. 28(7): p. 1507-17.
67. Winek, K., Engel, O., Koduah, P., et al., Depletion of Cultivatable Gut Microbiota by Broad-Spectrum Antibiotic Pretreatment Worsens Outcome After Murine Stroke. Stroke, 2016. 47(5): p. 1354-63.
68. Meisel, C., Schwab, J.M., Prass, K., Meisel, A., and Dirnagl, U., Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci, 2005. 6(10): p. 775-86.
69. Schulte-Herbruggen, O., Quarcoo, D., Meisel, A., and Meisel, C., Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation, 2009. 16(3): p. 213-8.
70. Sun, J., Wang, F., Ling, Z., et al., Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Res, 2016.
71. Winek, K., Meisel, A., and Dirnagl, U., Gut microbiota impact on stroke outcome: Fad or fact? J Cereb Blood Flow Metab, 2016. 36(5): p. 891-8.
72. Felice, V.D., Quigley, E.M., Sullivan, A.M., O'Keeffe, G.W., and O'Mahony, S.M., Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord, 2016.
73. Chen, J., Chia, N., Kalari, K.R., et al., Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep, 2016. 6: p. 28484.
74. Jangi, S., Gandhi, R., Cox, L.M., et al., Alterations of the human gut microbiome in multiple sclerosis. Nat Commun, 2016. 7: p. 12015.
75. Swidsinski, A.L.-B., V.; Krüger, M.; Kirsch, S., Central Nervous System and the Colonic Bioreactor: Analysis of Colonic Microbiota in Patients with Stroke Unravels Unknown Mechanisms of the Host Defense after Brain Injury. Intest Res, 2012. 10(4): p. 332-342.
76. Zhu, W., Gregory, J.C., Org, E., et al., Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell, 2016. 165(1): p. 111-24.
77. Wang, Z., Klipfell, E., Bennett, B.J., et al., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 2011. 472(7341): p. 57-63.
78. Koren, O., Spor, A., Felin, J., et al., Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A, 2010. 108 Suppl 1: p. 4592-8.
79. Tang, W.H., Wang, Z., Levison, B.S., et al., Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 2013. 368(17): p. 1575-84.
80. Koeth, R.A., Wang, Z., Levison, B.S., et al., Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med, 2013. 19(5): p. 576-85.
81. Karlsson, F.H., Fak, F., Nookaew, I., et al., Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 2012. 3: p. 1245.
82. Skagen, K., Troseid, M., Ueland, T., et al., The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Atherosclerosis, 2016. 247: p. 64-9.
83. Meir, K.S. and Leitersdorf, E., Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol, 2004. 24(6): p. 1006-14.
84. Collins, H.L., Drazul-Schrader, D., Sulpizio, A.C., et al., L-Carnitine intake and high trimethylamine Noxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP. Atherosclerosis, 2016. 244: p. 29-37.
85. Stepankova, R., Tonar, Z., Bartova, J., et al., Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb, 2010. 17(8): p. 796-804.
86. Singh, V., Yeoh, B.S., and Vijay-Kumar, M., Gut microbiome as a novel cardiovascular therapeutic target. Curr Opin Pharmacol, 2016. 27: p. 8-12.
87. Hartstra, A.V., Bouter, K.E., Backhed, F., and Nieuwdorp, M., Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care, 2015. 38(1): p. 159-65.
88. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., et al., A core gut microbiome in obese and lean twins. Nature, 2009. 457(7228): p. 480-4.
89. Backhed, F., Ding, H., Wang, T., et al., The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A, 2004. 101(44): p. 15718-23.
90. Backhed, F., Manchester, J.K., Semenkovich, C.F., and Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A, 2007. 104(3): p. 979-84.
91. Fu, J., Bonder, M.J., Cenit, M.C., et al., The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids. Circ Res, 2015. 117(9): p. 817-24.
92. Durgan, D.J., Ganesh, B.P., Cope, J.L., et al., Role of the Gut Microbiome in Obstructive Sleep Apnea- Induced Hypertension. Hypertension, 2016. 67(2): p. 469-74.
93. Santisteban, M.M., Kim, S., Pepine, C.J., and Raizada, M.K., Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics. Circ Res, 2016. 118(8): p. 1327-36.
94. Wang, Z., Roberts, A.B., Buffa, J.A., et al., Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell, 2015. 163(7): p. 1585-95.
95. Langhorne, P., Stott, D.J., Robertson, L., et al., Medical complications after stroke: a multicenter study. Stroke, 2000. 31(6): p. 1223-9.
96. Westendorp, W.F., Nederkoorn, P.J., Vermeij, J.D., Dijkgraaf, M.G., and de Beek, D., Post-stroke infection: A systematic review and meta-analysis. BMC neurology, 2011. 11: p. 110.
97. Latorre, M., Krishnareddy, S., and Freedberg, D.E., Microbiome as mediator: Do systemic infections start in the gut? World J Gastroenterol, 2015. 21(37): p. 10487-92.
98. Schuijt, T.J., Lankelma, J.M., Scicluna, B.P., et al., The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut, 2016. 65(4): p. 575-83.
99. Dickson, R.P. and Cox, M.J., The premature invocation of a 'gut-lung axis' may obscure the direct effects of respiratory microbiota on pneumonia susceptibility. Gut, 2016.
100. Langdon, A., Crook, N., and Dantas, G., The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med, 2016. 8(1): p. 39.
101. Jernberg, C., Lofmark, S., Edlund, C., and Jansson, J.K., Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J, 2007. 1(1): p. 56-66.
102. Meisel, A. and Smith, C.J., Prevention of stroke-associated pneumonia: where next? Lancet, 2015.
103. Springer, J., Schust, S., Peske, K., et al., Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia. Stroke, 2014. 45(12): p. 3675-83.
104. Scherbakov, N., Dirnagl, U., and Doehner, W., Body weight after stroke: lessons from the obesity paradox. Stroke; a journal of cerebral circulation, 2011. 42(12): p. 3646-50.
105. Turnbaugh, P.J., Backhed, F., Fulton, L., and Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe, 2008. 3(4): p. 213-23.
106. Bindels, L.B., Beck, R., Schakman, O., et al., Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One, 2012. 7(6): p. e37971.
107. Robinson, R.G. and Jorge, R.E., Post-Stroke Depression: A Review. Am J Psychiatry, 2016. 173(3): p. 221-31.
108. Fetissov, S.O. and Dechelotte, P., The new link between gut-brain axis and neuropsychiatric disorders. Curr Opin Clin Nutr Metab Care, 2011. 14(5): p. 477-82.
109. Yarandi, S.S., Peterson, D.A., Treisman, G.J., Moran, T.H., and Pasricha, P.J., Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases. J Neurogastroenterol Motil, 2016. 22(2): p. 201-12.
110. Forsythe, P., Sudo, N., Dinan, T., Taylor, V.H., and Bienenstock, J., Mood and gut feelings. Brain Behav Immun, 2010. 24(1): p. 9-16.
111. Jiang, H., Ling, Z., Zhang, Y., et al., Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun, 2015. 48: p. 186-94.
112. Jia, W., Li, H., Zhao, L., and Nicholson, J.K., Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov, 2008. 7(2): p. 123-9.
113. Ashraf, R. and Shah, N.P., Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr, 2014. 54(7): p. 938-56.
114. Besselink, M.G., van Santvoort, H.C., Renooij, W., et al., Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg, 2009. 250(5): p. 712-9.
115. Gooszen, H.G. and Dutch Pancreatitis Study, G., The PROPATRIA trial: best practices at the time were followed. Lancet, 2010. 375(9722): p. 1249-50.
116. Dani, C., Coviello, C.C., Corsini, I.I., Arena, F., Antonelli, A., and Rossolini, G.M., Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep, 2016. 6(1): p. e25-9.
117. Oggioni, M.R., Pozzi, G., Valensin, P.E., Galieni, P., and Bigazzi, C., Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol, 1998. 36(1): p. 325-6.
118. Kochan, P., Chmielarczyk, A., Szymaniak, L., et al., Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient--is the time right to revise probiotic safety guidelines? Clin Microbiol Infect, 2011. 17(10): p. 1589-92.
119. Eiseman, B., Silen, W., Bascom, G.S., and Kauvar, A.J., Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 1958. 44(5): p. 854-9.
120. van Nood, E., Vrieze, A., Nieuwdorp, M., et al., Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med, 2013. 368(5): p. 407-15.
121. Vermeire, S., Joossens, M., Verbeke, K., et al., Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis, 2016. 10(4): p. 387-94.
122. Petrof, E.O., Gloor, G.B., Vanner, S.J., et al., Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome, 2013. 1(1): p. 3.
123. Didesch, M.M., Averill, A., and Oh-Park, M., Peripheral Neuropathy After Fecal Microbiota Transplantation for Clostridium difficile Infection: A Case Report. PM R, 2016.
124. Gregory, J.C., Buffa, J.A., Org, E., et al., Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem, 2015. 290(9): p. 5647-60.
125. Perie-FlomCenter, Bill of Health http://blogs.harvard.edu/billofhealth/2016/03/01/fda-announces-draftguidance-that-would-limit-enforcement-discretion-for-fmt. Accessed on 29th of March 2016.
126. Belizario, J.E. and Napolitano, M., Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol, 2015. 6: p. 1050.
127. Chow, J. and Mazmanian, S.K., Getting the bugs out of the immune system: do bacterial microbiota "fix" intestinal T cell responses? Cell Host Microbe, 2009. 5(1): p. 8-12.
128. Maslowski, K.M., Vieira, A.T., Ng, A., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 2009. 461(7268): p. 1282-6.
129. Spanogiannopoulos, P., Bess, E.N., Carmody, R.N., and Turnbaugh, P.J. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol, 2016. 14(5): p. 273-87.
130. Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., and Basit, A.W. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm, 2008. 363(1-2): p. 1-25.
131. Haiser, H.J. and Turnbaugh, P.J. Is it time for a metagenomic basis of therapeutics? Science, 2012. 336(6086): p. 1253-5.
132. Wallace, B.D., Wang, H., Lane, K.T., et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science, 2010. 330(6005): p. 831-5.
133. Vetizou, M., Pitt, J.M., Daillere, R., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science, 2015. 350(6264): p. 1079-84.
134. Sivan, A., Corrales, L., Hubert, N., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science, 2015. 350(6264): p. 1084-9.
135. Lemon, K.P., Armitage, G.C., Relman, D.A., and Fischbach, M.A. Microbiota-targeted therapies: an ecological perspective. Sci Transl Med, 2012. 4(137): p. 137rv5.
136. Kleiman, S.C., Watson, H.J., Bulik-Sullivan, E.C., et al. The intestinal microbiota in acute anorexia nervosa and during renourishment: relationship to depression, anxiety, and eating disorder psychopathology. Psychosom Med, 2015. 77(9): p. 969- 981.
137. Krajmalnik-Brown, R., Lozupone, C., Kang, D.W., and Adams, J.B. Gut bacteria in children with autism spectrum disorders: challenges and promise of studying how a complex community influences a complex disease. Microb Ecol Health Dis 2015. 26: p. 26914.